Review Article

Total Ischemic Time as an Independent Predictor of Response to Stem Cell Therapy in Patients with ST Segment Elevation Myocardial Infarction

Table 1

Characteristics of studies.

TrialPatient number SC dose 
(million)
Followup 
(months)
Time to PCI (hours) SC delivery 
Time (days)
LVEF method
BMSC/PlaceboBMSC Placebo

Short termWollert et al., 2004 BOOST [6]30/302460 (940)69.8 (2.0–22)*8.0 (3.0–120)*4.8 (1.3)MRI
Chen et al., 2004 [9]34/35(8000–10000)*68.3 (3.8)8.5 (3.9)18.4 (0.5)Angio/PET
Janssens et al., 2006 [2]33/34172 (72)43.7 (2.5–7.6)*4.1 (3.1–8.3)*<1.0MRI
Schächinger et al., 2006 REPAIR-AMI [8]95/92236 (174)44.5*4.5*4.3 (1.3)Angio/PET
Ge et al., 2006 TCT-STAMI [10]10/1038.7 (21.6)67.9 (3.8)7.1 (3.1)<1.0Echo
Lunde et al., 2006 ASTAMI [3]45/4487.1 (47.7)63.5 (3.0–5.5)*3.8 (3.0–5.5)*6.0 (4.0–7.0)*MRI
Meluzín et al., 2008 [16]20/20100 (90–200)*67.2 (2.7)9.2 (3.4)6.8 (0.3)Echo
Penicka et al., 2007 +++++ [17]14/102640 (1960–3300)45.2 (5.0–11)*5.2 (5.0–11)*9.0 (4.0–11)*Echo
Tendera et al., 2009 REGENT [4]80/4017865.2 (2.0–16.7)*5.0 (2.0–22)*7.0 (3.0–12)*MRI
Plewka et al., 2009 [12]38/18144 (49)67.0 (2.0)8.0 (3.0)7.0 (2.0)Echo
Grajek et al., 2010 [5]31/14410 (180)64.8 (3.9)3.2 (3.5)(4.0–6.0)*Echo
Piepoli et al., 2010 [18]19/1941864.1 (1.1)4.4 (0.6)4.0 (1.0)Angio/PET
Traverse et al., 2010 [19]30/1010066.5 (4.3)2.9 (2.8–10.6)*5.2 (2.3)MRI

Long termMeyer et al., 2006 BOOST [20]30/302460 (940)189.8 (2.0–22)*8.0 (3.0–120)*4.8 (1.3)MRI
Meluzín et al., 2008 [16]20/20100 (90–200)*127.2 (2.7)9.2 (3.4)6.8 (0.3)Echo
Beitnes et al., 2009 ASTAMI [21]50/5068 (54–130)*363.5 (3.0–5.5)*3.8 (3.0–5.5)*6.0 (4.0–7.0)*MRI
Yousef et al., 2009 BALANCE [22]62/6261 (39)6010 (9.0)10 (9.0)7.0 (2.0)Angio/PET
Grajek et al., 2010 [5]31/14410 (180)124.8 (3.9)3.2 (3.5)(4.0–6.0)*Echo
Assmus et al., 2010 REPAIR-AMI CMR-Subs [23]26/33236 (174)127.5 (8.0)7.0 (6.5)4.4 (1.4)MRI
Piepoli et al., 2010 [18]19/19418124.1 (1.1)4.4 (0.6)4.0 (1.0)Angio/PET

All values are listed as “mean (SD)” unless otherwise denoted.
*Median (range).